Covigilant Research, LLC Clinical Trials Site Management Organization

Covigilant Research, LLC

Committed To Working Together

Mixed Response to the CMS Decision on Coverage for Aducanumab – Neurology Today,

Other payers have declined to cover the drug, saying that the failure of two clinical trials to demonstrate clear clinical benefit renders aducanumab …, Other payers have declined to cover the drug, saying that the failure of two clinical trials to demonstrate clear clinical benefit renders aducanumab …, Read More

Scroll to Top